Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07422090Recruiting

Preventing Suicide With Digital Phenotyping and Pharmacogenetics-Based Interventions

Role: collaborator

NCT07290868Not ApplicableNot Yet Recruiting

Diactive-1: Scaled-up Personalized mHealth Program for Youth With Type 1 Diabetes

Role: collaborator

NCT07264231Not ApplicableEnrolling By Invitation

Exercise During Pregnancy: Effects on the Maternal-Fetal Unit

Role: collaborator

NCT06999343Phase 3Not Yet Recruiting

Exploring the Anti-ageing Effects of Metformin in COPD

Role: lead

All 4 trials loaded